BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9765455)

  • 1. Role of variable regions A and B in receptor binding domain of amphotropic murine leukemia virus envelope protein.
    Han JY; Zhao Y; Anderson WF; Cannon PM
    J Virol; 1998 Nov; 72(11):9101-8. PubMed ID: 9765455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
    Tailor CS; Kabat D
    J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor.
    Battini JL; Danos O; Heard JM
    J Virol; 1998 Jan; 72(1):428-35. PubMed ID: 9420242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive approach to mapping the interacting surfaces of murine amphotropic and feline subgroup B leukemia viruses with their cell surface receptors.
    Tailor CS; Nouri A; Kabat D
    J Virol; 2000 Jan; 74(1):237-44. PubMed ID: 10590111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes.
    Lavillette D; Maurice M; Roche C; Russell SJ; Sitbon M; Cosset FL
    J Virol; 1998 Dec; 72(12):9955-65. PubMed ID: 9811733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.
    Wu BW; Lu J; Gallaher TK; Anderson WF; Cannon PM
    Virology; 2000 Mar; 269(1):7-17. PubMed ID: 10725193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entry of amphotropic murine leukemia virus is influenced by residues in the putative second extracellular domain of its receptor, Pit2.
    Leverett BD; Farrell KB; Eiden MV; Wilson CA
    J Virol; 1998 Jun; 72(6):4956-61. PubMed ID: 9573264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses.
    Battini JL; Heard JM; Danos O
    J Virol; 1992 Mar; 66(3):1468-75. PubMed ID: 1310758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU.
    Ott D; Rein A
    J Virol; 1992 Aug; 66(8):4632-8. PubMed ID: 1321266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-binding domain of murine leukemia virus envelope glycoproteins.
    Battini JL; Danos O; Heard JM
    J Virol; 1995 Feb; 69(2):713-9. PubMed ID: 7815534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.
    Sugai J; Eiden M; Anderson MM; Van Hoeven N; Meiering CD; Overbaugh J
    J Virol; 2001 Aug; 75(15):6841-9. PubMed ID: 11435563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses.
    O'Reilly L; Roth MJ
    J Virol; 2000 Jan; 74(2):899-913. PubMed ID: 10623753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amphotropic and ecotropic murine leukemia virus envelope TM subunits are equivalent mediators of direct membrane fusion: implications for the role of the ecotropic envelope and receptor in syncytium formation and viral entry.
    Ragheb JA; Yu H; Hofmann T; Anderson WF
    J Virol; 1995 Nov; 69(11):7205-15. PubMed ID: 7474142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of the N termini of murine leukemia virus envelope proteins.
    Lu CW; Roth MJ
    J Virol; 2001 May; 75(9):4357-66. PubMed ID: 11287584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional interaction between the N- and C-terminal domains of murine leukemia virus surface envelope protein.
    Lu CW; Roth MJ
    Virology; 2003 May; 310(1):130-40. PubMed ID: 12788637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphotropic murine leukemia virus entry is determined by specific combinations of residues from receptor loops 2 and 4.
    Lundorf MD; Pedersen FS; O'Hara B; Pedersen L
    J Virol; 1999 Apr; 73(4):3169-75. PubMed ID: 10074169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.
    Boomer S; Eiden M; Burns CC; Overbaugh J
    J Virol; 1997 Nov; 71(11):8116-23. PubMed ID: 9343161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the mutation Q252R in activating membrane fusion in the murine leukemia virus surface envelope protein.
    Lu CW; Roth MJ
    J Virol; 2003 Oct; 77(20):10841-9. PubMed ID: 14512534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of conformational and cold-sensitive mutations in the MuLV envelope protein.
    O'Reilly L; Roth MJ
    Virology; 2003 Aug; 312(2):337-49. PubMed ID: 12919739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU.
    Burkhart MD; Kayman SC; He Y; Pinter A
    J Virol; 2003 Apr; 77(7):3993-4003. PubMed ID: 12634359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.